Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology (2018)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.12.986
PubMed Identifier: 29360527
Publication URI: http://europepmc.org/abstract/MED/29360527
Type: Journal Article/Review
Parent Publication: Journal of Allergy and Clinical Immunology
Issue: 4
ISSN: 0091-6749